Detalhe da pesquisa
1.
Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
Clin Infect Dis
; 73(7): e2424-e2435, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920641
2.
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
Lancet Microbe
; 5(6): e581-e593, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761816
3.
IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
PLoS One
; 16(8): e0256396, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415964
4.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One
; 16(9): e0256980, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495988
5.
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
PLoS One
; 15(6): e0233840, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32555601